http://simmaronresearch.com/2019/04...yuZr3aRdOMYIbhJ6aYngnQ6VmdlegtBuLAsqut7BQ0Css
Dr. Nath will be speaking on the Intramural study at the NIH conference. He’s reported that he will present on the high rate of rare diseases found during the first half of the study, but with just half of the projected participants having finished the first part of a two-part study, it’s not clear whether he will have any biological results to present. (He has called producing hypotheses based on few results the “kiss of death”.)
Nath and his compatriots uncovered the antibody connection to nodding disease seven years ago – a long time in this age of fast moving medical technology. Nath reported he’ll be using a newer approach involving mass spectrometry, or phage display, in ME/CFS which will allow him to “probe almost infinite numbers of proteins/peptides”.
Dr. Nath will be speaking on the Intramural study at the NIH conference. He’s reported that he will present on the high rate of rare diseases found during the first half of the study, but with just half of the projected participants having finished the first part of a two-part study, it’s not clear whether he will have any biological results to present. (He has called producing hypotheses based on few results the “kiss of death”.)
Nath and his compatriots uncovered the antibody connection to nodding disease seven years ago – a long time in this age of fast moving medical technology. Nath reported he’ll be using a newer approach involving mass spectrometry, or phage display, in ME/CFS which will allow him to “probe almost infinite numbers of proteins/peptides”.